AMPEL BioSolutions announced the launch of LuGENE®, an exciting breakthrough innovation in systematic lupus erythematosus (SLE) care. LuGENE® is a new blood test designed to predict SLE flares before ...
BARCELONA, Spain — Monitoring blood hydroxychloroquine levels could help to ensure that patients with systemic lupus erythematosus (SLE) are being treated with the drug optimally, according to ...
The optimal hydroxychloroquine blood level in lupus is between 750 ng/mL and 1,150 ng/mL, which can help prevent active ...
Study: Biomarkers in maternal blood may predict risk for adverse outcomes in pregnant women with SLE
Pregnant women with systemic lupus erythematosus (SLE), are at higher risk for adverse pregnancy outcomes, including preeclampsia, placental insufficiency, fetal death, miscarriages, and other ...
11d
10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease
Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a collaboration with Brigham & Women's Hospital, a world-class academic medical center, to analyze peripheral ...
In patients with antiphospholipid syndrome (APS), isolated antiphospholipid antibodies, and/or systemic lupus erythematosus (SLE), elevated plasma levels of soluble triggering receptor expressed on ...
From 1999-2020, systemic lupus erythematosus (SLE)-related mortality rates consistently declined across demographic groups. Rates remain disproportionately high among Black and female patients. The ...
WILMINGTON, Del.--(BUSINESS WIRE)--Positive high-level results from a pre-specified interim analysis of the Phase III TULIP-SC trial in patients with systemic lupus erythematosus (SLE) showed that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback